Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review

BACKGROUND: Metastatic triple-negative breast cancer (mTNBC), an aggressive histological subtype, has poor prognosis. Chemotherapy remains standard of care for mTNBC, although no agent has been specifically approved for this breast cancer subtype. Instead, chemotherapies approved for metastatic brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Claire H., Karantza, Vassiliki, Aktan, Gursel, Lala, Mallika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916124/
https://www.ncbi.nlm.nih.gov/pubmed/31842957
http://dx.doi.org/10.1186/s13058-019-1210-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916124/
https://www.ncbi.nlm.nih.gov/pubmed/31842957
http://dx.doi.org/10.1186/s13058-019-1210-4

Ejemplares similares